Dimensional Fund Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-537,503
Closed -$22.2M 3409
2015
Q2
$22.2M Sell
537,503
-1,044
-0.2% -$37.4K 0.01% 1749
2015
Q1
$19M Sell
538,547
-1,380
-0.3% -$46.7K 0.01% 1846
2014
Q4
$17.3M Buy
539,927
+2,310
+0.4% +$66.8K 0.01% 1884
2014
Q3
$15.1M Buy
537,617
+2,151
+0.4% +$65.5K 0.01% 1894
2014
Q2
$16.2M Sell
535,466
-3,532
-0.7% -$97.5K 0.01% 1853
2014
Q1
$14.9M Sell
538,998
-1,588
-0.3% -$41.6K 0.01% 1852
2013
Q4
$13.8M Sell
540,586
-9,467
-2% -$292K 0.01% 1902
2013
Q3
$16.4M Buy
550,053
+2,104
+0.4% +$58.5K 0.01% 1652
2013
Q2
$15.8M Buy
+547,949
New +$15.1M 0.01% 1567

Other funds holding BRLI

Dimensional Fund Advisors's BRLI Position: Q3 2015 in Review

Dimensional Fund Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 537,503 shares — an estimated $22.2M sold.

Dimensional Fund Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $22.2M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Dimensional Fund Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 537,503 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $22.2M.
  • Dimensional Fund Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Dimensional Fund Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $22.2M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Dimensional Fund Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.